EBS vs UPS · rev $1.04B vs P/E 15, rev $88.66B
Emergent Biosolutions Inc (EBS) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
EBS currently screens at market cap $416.4M. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the EBS and UPS stock pages for the full models.
Not investment advice.